Showing results (11-20 of 854) with videos related to
Sort By:
Pageof 86
Handbook of Experimental Pharmacology|November 26, 2008
Induction of tolerogenic dendritic cells by vitamin D receptor agonistsLuciano Adorini, Giuseppe PennaNature Clinical Practice. Rheumatology|July 3, 2008
Control of autoimmune diseases by the vitamin D endocrine systemLuciano Adorini, Giuseppe PennaExpert Opinion on Therapeutic Targets|September 20, 2006
The vitamin D receptor as a therapeutic targetMoray J Campbell, Luciano AdoriniSeminars in Immunology|March 24, 2004
Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsLuciano Adorini, Nadia Giarratana, Giuseppe PennaMethods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouseNadia Giarratana, Giuseppe Penna, Luciano AdoriniDrug Discovery Today|June 2, 2012
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitisLuciano Adorini, Mark Pruzanski, David ShapiroCurrent Topics in Medicinal Chemistry|July 20, 2006
Vitamin D receptor agonists, cancer and the immune system: an intricate relationshipLuciano Adorini, Kenn C Daniel, Giuseppe PennaTrends in Molecular Medicine|February 14, 2002
Understanding autoimmune diabetes: insights from mouse modelsLuciano Adorini, Silvia Gregori, Leonard C HarrisonTransplantation|July 9, 2005
Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonistSusana Amuchastegui, Kenn C Daniel, Luciano AdoriniHepatology (Baltimore, Md.)|October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputAnna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.Pageof 86